Enterprise League logo
Immunovant Logo

Immunovant

New York, United States (US) · Health and Medical

Do you work at Immunovant?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

#autoimmune disease

Immunovant is a US-based clinical-stage immunology company, headquartered in New York, dedicated to developing innovative therapies for autoimmune diseases.We are a group of bold trailblazers committed to using our enterprising spirit to enable normal lives for people with autoimmune diseases.

Overview

Immunovant is a US-based clinical-stage immunology company, headquartered in New York, dedicated to developing innovative therapies for autoimmune diseases.

We are a group of bold trailblazers committed to using our enterprising spirit to enable normal lives for people with autoimmune diseases. Patients Are Waiting – Patients are our purpose and north star. We act with urgency because lives depend on it.

What sets Immunovant apart is our focus on anti-FcRn technology, driving a pipeline of targeted therapies to meet the complex and variable needs of patients. We champion an environment where all feel a sense of belonging by promoting a creative and collaborative workplace that leads to genuine connection and innovation.

At Immunovant, we offer comprehensive benefits, including career investment, health & wellness programs, and a generous equity incentive plan, reflecting our commitment to our employees’ growth and well-being. We welcome you to bring your whole, authentic self on this journey.
Visit Official Website

Most teams do this before shortlisting


Contact Details

info@immunovant.com

New York, United States (US), 320 W 37th St

+1

Founded

2018

Company Type

Public Limited Company

Employees

200-500

Categories

Biopharma
Life Science
Biotechnology

Keywords

#autoimmune disease

Awards

• 2026 OpenSee all

Services

Default Product Image
Anti-FcRn Therapies
Biotechnology

Immunovant is developing a portfolio of anti-FcRn therapies targeting autoimmune diseases. These therapies aim to modulate immune responses and improve patient outcomes.

N/A

Companies teams usually look at after Immunovant

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.